Senti Biosciences grants new employees stock options to join the company

From GlobeNewswire: 2024-12-03 20:00:00

Senti Biosciences, Inc. granted three new employees stock options to purchase 49,778 shares of the Company’s common stock at $2.11 per share on November 26, 2024, under the 2022 Inducement Equity Plan. These awards were made to induce the employees to join the Company, in accordance with NASDAQ Listing Rule 5635(c)(4) and the terms of the Plan adopted on August 5, 2022. Senti Bio is a clinical-stage biotechnology company developing next-generation cell and gene therapies using its Gene Circuit platform to target incurable diseases with enhanced precision and control. Learn more on their website or social media platforms.



Read more at GlobeNewswire: Senti Biosciences Announces New Employment Inducement